Literature DB >> 3260888

[Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].

E M Lemmel, I Stroehmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3260888

Source DB:  PubMed          Journal:  Fortschr Med        ISSN： 0015-8178


× No keyword cloud information.
  5 in total

1.  Efficacy and safety of nabumetone in 4,541 elderly patients from a drug monitoring study.

Authors:  P Münzel; E E Lemmel
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Efficacy and safety of nabumetone in patients with rheumatic diseases. Results of an outpatient study involving 8,865 patients.

Authors:  I Stroehmann; K H Giersch; H Zeidler; P Münzel
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Efficacy and safety of nabumetone in 5,421 patients with osteoarthritis of the hip and/or knee joints. A subgroup evaluation of an outpatient study involving 18,047 patients.

Authors:  M Fedder; I Stroehmann
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  German drug monitoring studies with nabumetone.

Authors:  I Stroehmann; M Fedder; H Zeidler
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.

Authors:  H A Friedel; H D Langtry; M M Buckley
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.